KAYE RANDALL (CMO) reported 1 transaction at LONGBOARD PHARMACEUTICALS, INC.
Review the transaction codes below to understand the nature of each event.
Common Stock
Shares
−30.55K
Price / share
$60.00
Trade value
$1.83M
% of position
Net shares
−30.55K
Net value
-$1.83M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/2/2024 | U · U | −30.55K | $60.00 | $1.83M | New position | 30.55K | 0.00 |
| Total | −30.55K | -$1.83M | ||||||
Employee Stock Option (right to buy)
Common Stock
175.95K shares
Shares
−175.95K
Strike price
6
Held after
0.00
Exercisable
—
Employee Stock Option (right to buy)
Common Stock
96.30K shares
Shares
−96.30K
Strike price
4.35
Held after
0.00
Exercisable
—
Employee Stock Option (right to buy)
Common Stock
107.56K shares
Shares
−107.56K
Strike price
19.32
Held after
0.00
Exercisable
—
Restricted Stock Unit
Common Stock
17.92K shares
Shares
−17.92K
Strike price
Held after
0.00
Exercisable
—
Restricted Stock Unit
Common Stock
9.50K shares
Shares
−9.50K
Strike price
Held after
0.00
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy) Direct | Common Stock175.95K shares | 12/2/2024 | D · Disposition | −175.95K | 6 | — | 0.00 |
| Employee Stock Option (right to buy) Direct | Common Stock96.30K shares | 12/2/2024 | D · Disposition | −96.30K | 4.35 | — | 0.00 |
| Employee Stock Option (right to buy) Direct | Common Stock107.56K shares | 12/2/2024 | D · Disposition | −107.56K | 19.32 | — | 0.00 |
| Restricted Stock Unit Direct | Common Stock17.92K shares | 12/2/2024 | D · Disposition | −17.92K | — | 0.00 | |
| Restricted Stock Unit Direct | Common Stock9.50K shares | 12/2/2024 | D · Disposition | −9.50K | — | 0.00 |